03:30 AM EST, 11/14/2025 (MT Newswires) -- Michael Thomas Henderson, Director, Chief Executive Officer, on November 13, 2025, sold 20,000 shares in Apogee Therapeutics ( APGE ) for $1,260,236. Following the Form 4 filing with the SEC, Henderson has control over a total of 1,272,987 common shares of the company, with 1,272,987 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1974640/000110465925111626/xslF345X05/tm2531267-1_4seq1.xml